NextCure
MD - BeltsvilleBiotechnology
Focus: NextCure is an early-stage oncology-focused biotechnology company developing immune therapies for cancer, headquartered in Beltsville, Maryland. The company operates at the pre-revenue stage with a pipeline spanning multiple modalities across hematologic and solid tumors.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
3
Should You Work at NextCure?
AI assessmentBest suited for early-career scientists seeking immuno-oncology expertise and intellectual challenge, but career risk exists due to pre-revenue stage, minimal hiring, and substantial capital/milestone uncertainties.
Why Work Here
- Opportunity to work on novel immuno-oncology mechanisms with 8 active trials across Phase 1/2 programs, including NC318 and NC410 in advanced solid tumors
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
10 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LNCB74
Ovarian CancerPhase 1
Clinical Trials (1)
Help build intelligence for NextCure
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.